Trends in species causing fungaemia in a tertiary care medical centre over 12 years
- 1 December 2001
- Vol. 44 (11-12) , 446-449
- https://doi.org/10.1046/j.1439-0507.2001.00662.x
Abstract
Summary. Trends in the species of yeast causing fungaemia over a 12-year period at a large tertiary care medical centre were reviewed. A total of 966 unique episodes of fungaemia occurred in 898 patients. There was an overall trend toward fewer fungaemic episodes due to Candida albicans and more due to Candida glabrata and Candida parapsilosis. However, C. albicans remained the predominant species causing fungaemia, and the proportion due to other species varied from year to year. Candida glabrata was disproportionately isolated from older adults, whereas C. parapsilosis was common among neonates and infants. The trends of increasing isolation of C. glabrata and decreasing isolation of C. albicans were associated with increasing usage of fluconazole, but changes in the proportion of fungaemias due to other species appeared to have no association with fluconazole usage. Zusammenfassung. U¨ber eine 12-Jahresperiode hin wurden in einer Großklinik die Hefeisolate von Funga¨mie-Patienten statistisch erfasst. Bei 898 Patienten wurden 966 Funga¨mie-Episoden beobachtet. Insgesamt zeigte sich ein Trend zu weniger Funga¨mie-Episoden durch Candida albicans und zu mehr durch Candida glabrata und Candida parapsilosis. Trotzdem blieb C. albicans die dominante Art als Funga¨mie-Erreger; der Anteil anderer Hefearten variierte von Jahr zu Jahr. Candida glabrata wurde relativ ha¨ufiger von a¨lteren Patienten isoliert, C. parapsilosis ha¨ufiger von Neugeborenen und Kindern. Die Trends zunehmender Isolierung von C. glabrata und sinkender Isolierungsha¨ufigkeit von C. albicans waren mit dem steigenden Einsatz von Fluconazol assoziiert. A¨nderungen in den Anteilen der Funga¨mie-Fa¨lle durch andere Arten zeigten jedoch keine Beziehung zum Fluonazol-Einsatz.Keywords
This publication has 15 references indexed in Scilit:
- Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic FluconazoleThe Journal of Infectious Diseases, 2000
- The Epidemiology of Candidemia in Two United States Cities: Results of a Population-Based Active SurveillanceClinical Infectious Diseases, 1999
- National Epidemiology of Mycoses Survey (NEMIS): Variations in Rates of Bloodstream Infections Due to Candida Species in Seven Surgical Intensive Care Units and Six Neonatal Intensive Care UnitsClinical Infectious Diseases, 1999
- Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)Clinical Infectious Diseases, 1999
- National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE ProgramDiagnostic Microbiology and Infectious Disease, 1998
- Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitalsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistanceThe American Journal of Medicine, 1996
- Candidaglabrata, Candidakrusei, Non-albicans Candida spp., and Other Fungal Organisms in a Sixty-Bed National Cancer Center in 1989-1993: No Association with the Use of FluconazoleChemotherapy, 1995
- Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year periodAntimicrobial Agents and Chemotherapy, 1994
- Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with FluconazoleNew England Journal of Medicine, 1991